Publications by authors named "Fabian Diez"
Ther Adv Respir Dis
November 2022
Article Synopsis
- Pulmonary arterial hypertension (PAH) is a serious condition with high morbidity and mortality, and subcutaneous treprostinil is a preferred treatment for high-risk patients in Argentina.
- A study evaluated the efficacy and safety of treprostinil over 12 months in 51 PAH patients, showing significant improvements in functional class, distance walked, and heart function, alongside a high survival rate.
- The results support using subcutaneous treprostinil as a first-line therapy for high-risk PAH patients, validating its effectiveness and safety in everyday clinical settings.
